More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab

 
• By Anju Ghangurde
  
Rio
MYLAN-BIOCON HAVE RECEIVED APPROVAL FOR THEIR HERCEPTIN BIOSIMILAR IN BRAZIL
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip